Rediff Logo
Money
Line
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Women
Partner Channels: Bill Pay | Health | IT Education | Jobs | Travel
Line
Home > Money > Stocks > Corporate News
August 28, 2001
Feedback
Money Matters

 -  Business Special
 -  Business Headlines
 -  Corporate Headlines
 -  Columns
 -  IPO Center
 -  Message Boards
 -  Mutual Funds
 -  Personal Finance
 -  Stocks
 -  Tutorials
 -  Search rediff

    
      








3DSP & Wipro Tech partner to offer DSP solutions
Wipro Technologies, a leading software and hardware design house and 3DSP Corporation, the leader in configurable digital signal processor (DSP) architectures, today (August 28, 2001) announced that they would be offering DSP solutions under 3DSP Masterpiece partnership program.
Wipro & 3DSP are partnering in the development of MPEG-4 Video Software that is forward and backward compatible with the H-263 standard, and will continue the partnership to build other wireless and video applications on the 3DSP platform.
"We are pleased to partner with 3DSP under their masterpiece partnership program" said Mr M Divakaran, CEO of the Embedded and Internet Access division at Wipro. " With our expertise in embedded software, hardware design and our IP portfolio, we have the ability to target designs to different platforms and the skill to fuse the IP into the customer's design environment."

Infotech Enterprises achieves SEI CMM Level 4
Infotech Enterprises Ltd today (August 28, 2001) announced its achievement of SEI CMM Level 4 certification for its software development center in Infocity, Hyderabad.
Commenting on the achievement, Chairman & Managing Director BVR Mohan Reddy said, " We will continue to work towards better and better quality systems in the years to come. SEI CMM Level 4 is another positive step towards improving the quality systems in our organization. Quality, on-time delivery and our affordable cost matrix provides excellent value for money to customers who utilize our services. By further improving our quality and productivity, we will continue to move customer satisfaction to new levels."

Saurashtra Cement denies news item
With reference to news item "Saurashtra Cement moves BIFR to merge Sidhee" Saurashtra Cement has informed BSE that the company has not moved to BIFR to merge with Gujarat Sidhee Cement Ltd. Saurashtra Cement Ltd and Gujarat Sidhee Cement Ltd continue to function as two separate bodies under their respective Board of Directors.
The companies have been trying to optimise cost and improve productivity and number of initiatives have been taken to achieve these objectives. However the proposal to merge the company is not one of them.

Ranbaxy-Cipla to co-market Cipro OD
Ranbaxy and Cipla the two leading Indian Pharma companies today (August 28, 2001) announced their alliance to co-market Ranbaxy's once-a-day formulation of Ciprofloxacin, which has recently received DCGI approval for marketing in India. This unique dosage form of the broad-spectrum anti-bacterial is from Ranbaxy's Novel Drug Delivery Systems (NDDS) research pipeline.
Dr Brian W. Tempest, President-Pharmaceuticals, Ranbaxy Laboratories Ltd, commenting on the occasion said," The Ranbaxy-Cipla alliance will be a win-win situation for both companies, enabling to leverage its combined marketing prowess and extensive distribution network." He further added, "We are keen that the benefits of Ciprofloxacin OD in terms of convenience and better patient compliance should percolate to the maximum number of doctors and patients."
Mr. Amar Lulla, Joint Managing Director, Cipla commented, "The spirit of co-operation that was started a few years ago between Cipla & Ranbaxy has now been strengthened with the Ciprofloxacin OD agreement. Together, both our brands account for over 30% of the Ciprofloxacin market and thus we will be in a better position to convert the market towards the once-daily concept in this fragmented segment."
The development of the once-daily formulation of Ciprofloxacin will give a cutting edge to both companies for further consolidating their market share. The companies would be marketing the product under their brand names- CIFRAN OD (Ranbaxy) and CIPLOX OD (Cipla). Ranbaxy would manufacture the products for both companies.

Spanco Telesystems Board approves allotment of equity shares on preferential basis
Spanco Telesystems & Solutions Ltd has informed BSE that the Board of Directors of the company at its meeting held on August 25, 2001 has considered and approved allotment of 3 million equity shares of Rs.10/- each for cash at a premium of Rs.27/-per share aggregating Rs.11,10,00,000/- on preferential basis in accordance with the resolution passed by the members of the company at the EGM held on May 29, 2001.

Shri Dinesh Mills purchases 49% stake in JV
Shri Dinesh Mills Ltd has informed BSE that the company has purchased 10,29,000 equity shares of Rs.10/- each representing 49% of company's closely held joint venture company McGean Rohco Dinesh Ltd.(subject to the approval of RBI) from the joint venture partner McGean Rohco Inc. USA (MRI) due to world wide re-organisation of MRI business. Accordingly all the joint venture related agreement is terminated.

Kirloskar Brothers holds 34.10% equity of Kirloskar Oil Engines
Kirloskar Oil Engines Ltd has informed BSE that Kirloskar Brothers Ltd., has acquired 4,91,016 equity shares (2.56 % of the paid-up capital) of the company. With this, Kirloskar Brothers Ltd., aggregate shareholding in company is 65,36,632 equity shares (34.10 % of the paid up capital of the company.)

P&G Hygiene appoints Additional Directors
Mr C C Daley, Mr J Cua & Mr S Bhattacharya have resigned as Directors of Procter & Gamble Hygiene Health Care Ltd. Mr S Khosla and Mr P Smit have been appointed as Additional Directors of the company with effect from today (August 27, 2001).

BSE transfers 14 scrips to Normal Segment
BSE has informed the members of the exchange that the following scrips have been transferred to Normal Segment from Trade to Trade basis w.e.f. August 27, 2001.
S.No Scrip Code Scrip Name
1. 32403 Fourth Generation Information System Ltd.
2. 32015 Gravity (India) Ltd.
3. 31739 Prudential Pharmaceuticals Ltd.
4. 31637 Sword & Shield Pharma Ltd.
5. 26707 Toubro Infotech & Industries Ltd.
6. 32417 E.Star Infotech Ltd.
7. 31939 Genius Commu Trade ltd.
8. 23049 Rinki Petrochemicals & Industries Ltd.
9. 11525 SRG Infotech Ltd.
10. 17540 Nexus Software Ltd.
11. 31905 Accurate Exports Ltd.
12. 9079 Gufic Bio Sciences Ltd.
13. 32382 Balaji Telefilms Ltd.
14. 32357 Mukta Arts Ltd.

SSI fixes book closure for the purpose of Dividend
SSI Ltd has fixed October 09, 2001 to October 17, 2001 as Book Closure for the purpose of AGM and 60% Dividend (40%+20% Special Dividend).

Money

Rapid Information on Stocks & Corporates

Tell us what you think of this report

ADVERTISEMENT